+

WO2004058150A3 - Anti-infectives - Google Patents

Anti-infectives Download PDF

Info

Publication number
WO2004058150A3
WO2004058150A3 PCT/US2003/040133 US0340133W WO2004058150A3 WO 2004058150 A3 WO2004058150 A3 WO 2004058150A3 US 0340133 W US0340133 W US 0340133W WO 2004058150 A3 WO2004058150 A3 WO 2004058150A3
Authority
WO
WIPO (PCT)
Prior art keywords
infectives
disclosed
formula
making
methods
Prior art date
Application number
PCT/US2003/040133
Other languages
French (fr)
Other versions
WO2004058150A2 (en
Inventor
Duke M Fitch
Original Assignee
Smithkline Beecham Corp
Duke M Fitch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Duke M Fitch filed Critical Smithkline Beecham Corp
Priority to AU2003297235A priority Critical patent/AU2003297235A1/en
Publication of WO2004058150A2 publication Critical patent/WO2004058150A2/en
Publication of WO2004058150A3 publication Critical patent/WO2004058150A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds useful as HCV anti-infectives having the formula (I) wherein the formula variables are as defined herein, are disclosed. Also disclosed are methods of making and using the same.
PCT/US2003/040133 2002-12-17 2003-12-11 Anti-infectives WO2004058150A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003297235A AU2003297235A1 (en) 2002-12-17 2003-12-11 Anti-infectives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43422702P 2002-12-17 2002-12-17
US60/434,227 2002-12-17

Publications (2)

Publication Number Publication Date
WO2004058150A2 WO2004058150A2 (en) 2004-07-15
WO2004058150A3 true WO2004058150A3 (en) 2006-03-30

Family

ID=32682012

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/040133 WO2004058150A2 (en) 2002-12-17 2003-12-11 Anti-infectives

Country Status (2)

Country Link
AU (1) AU2003297235A1 (en)
WO (1) WO2004058150A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7902203B2 (en) * 2002-11-01 2011-03-08 Abbott Laboratories, Inc. Anti-infective agents
US7378414B2 (en) 2003-08-25 2008-05-27 Abbott Laboratories Anti-infective agents
EP1786807B1 (en) 2004-08-23 2009-07-29 F.Hoffmann-La Roche Ag Heterocyclic antiviral compounds
RU2388748C2 (en) 2004-12-21 2010-05-10 Ф. Хоффманн-Ля Рош Аг Tetralin and indane derivatives and use thereof as 5-ht antagonists
WO2006093801A1 (en) 2005-02-25 2006-09-08 Abbott Laboratories Thiadiazine derivatives useful as anti-infective agents
BRPI0611388A2 (en) 2005-05-04 2010-09-08 Hoffmann La Roche heterocyclic antiviral compounds, their use and pharmaceutical composition
AU2006310612A1 (en) 2005-11-03 2007-05-10 F. Hoffmann-La Roche Ag Arylsulfonylchromans as 5-HT6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors
EP1987027B1 (en) 2006-02-17 2010-12-15 F. Hoffmann-La Roche AG Heterocyclic antiviral compounds
CA2653758A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
BRPI0713502A2 (en) 2006-06-20 2012-03-13 F. Hoffmann-La Roche Ag arylsulfonamidyl tetraline derivatives and uses of these
WO2007147763A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Arylsulfonyl naphthalene derivatives and uses thereof
CA2665049C (en) 2006-10-10 2012-12-04 Medivir Ab Hcv nucleoside inhibitor
MX2011008641A (en) 2009-03-06 2011-09-06 Hoffmann La Roche Heterocyclic antiviral compounds.
CN102448936A (en) 2009-04-25 2012-05-09 弗·哈夫曼-拉罗切有限公司 Heterocyclic antiviral compounds
MX2011012541A (en) 2009-06-24 2012-08-03 Hoffmann La Roche Heterocyclic antiviral compound.
WO2011033045A1 (en) 2009-09-21 2011-03-24 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
KR20120085918A (en) 2009-11-21 2012-08-01 에프. 호프만-라 로슈 아게 Heterocyclic antiviral compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHOO Q L ET AL: "ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL HEPATITIS GENOME.", SCIENCE., vol. 244, 1989, pages 359 - 362, XP001093889 *

Also Published As

Publication number Publication date
WO2004058150A2 (en) 2004-07-15
AU2003297235A8 (en) 2004-07-22
AU2003297235A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
MXPA03011329A (en) Novel anti-infectives.
WO2003059356A3 (en) Novel anti-infectives
WO2004058150A3 (en) Anti-infectives
WO2004052313A3 (en) Anti-infectives
WO2004018451A8 (en) Pyridazinone-derivatives as pde4 inhibitors
WO2003035617A3 (en) Derivatives of uk-2a
WO2004018449A8 (en) Piperidine-derivatives as pde4 inhibitors
WO2005021497A3 (en) Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones
WO2005030791A3 (en) Isoquinolinone potassium channel inhibitors
AU2003222544A1 (en) Homing process
AU2003236527A1 (en) Compounds, compositions, and methods
WO2003037262A3 (en) Novel anit-infectives
IL158485A (en) Spiropyrazole compounds
WO2004069152A3 (en) Δ4,5 glycuronidase and uses thereof
AU2003299612A1 (en) Compounds, compositions and methods
WO2005030130A3 (en) Isoquinoline potassium channel inhibitors
EP1283235A3 (en) Composition, method of making, and method of using adhesive composition
AU2003281694A1 (en) 6,11-4-carbon bridged ketolides
AU2003277079A1 (en) Compounds, compositions, and methods
WO2004052312A3 (en) Anti-infectives
AU2001292320A1 (en) Benzylamine compound, process for producing the same, and intermediate therefor
AU2003290507A1 (en) Compounds, compositions and methods
WO2005005382A3 (en) Compounds, compositions and methods
AU2003201163A1 (en) Method for the preparation of lariciresinol, cyclolariciresinol and secoisolariciresinol
WO2004047751A3 (en) Calcilytic compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AU BA BB BR BZ CA CN CO CR CU DM DZ EC EG GD GE HR ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX NO NZ OM PH PL RO SC SG TN TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载